Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

faCellitate Appoints Christoph Petry Managing Director & CEO (2022-11-30)
faCellitate GmbH has appointed Dr. Christoph Petry, as Managing Director and CEO. Dr. Petry spun-out Sividon Diagnostics from Siemens Healthcare in 2010. Serving as Sividon’s CEO he oversaw the development of EndoPredict, a new standard to target breast cancer ...
BioNTech & Ryvu Therapeutics Announce Global Collaboration (2022-11-30)
> The companies enter a multi-target research collaboration to develop multiple small molecule programs targeting immune modulation in cancer and potentially other disease areas based on targets selected by BioNTech > In addition to these programs, BioNTech will...
BioWin Expands Its »Growth & Financing« Member Service (2022-11-29)
Nadia Verwilghen and Bernard Linsmeau will lead service offer to support biotech and medtech companies in accelerating business growth and raising funds in challenging markets BioWin, the health cluster of Wallonia, today announces the appointment of two growt...
MiGenTra, Bioventure, Minapharm & Alvotech: Biosimilars (2022-11-29)
Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH, a Berlin-based pharmaceutical company, announced today the signing of an exclusive license agreement for the commercialization of m...
AstraZeneca Acquires Neogene: up to $320m with $200m Upfront (2022-11-29)
Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumours AstraZeneca today announced an agreement to acquire Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company p...
V7 Raises $33m Series A to Help Build Robust AI, Faster (2022-11-28)
V7 announces $33m Series A financing co-led by AI-focused Radical Ventures and Temasek, with participation from Air Street Capital, Amadeus Capital, and Partech. > V7, the data engine for AI, announces a $33m Series A funding round, co-led by Radical Ventures an...
Plectonic GmbH: BMBF Loan to Advance Biological Nanoswitches (2022-11-28)
Plectonic Biotech, a spin-off of the Technical University of Munich (TUM), has developed a nanoswitch that binds immune cells to tumor cells. The goal is to facilitate the development of immunotherapies that target tumors specifically and have fewer side effects. T...
Hemispherian Closes 1st NOK30m Tranche of Series A1 Round (2022-11-24)
Hemispherian AS (“Hemispherian” or the “Company”), a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the DNA damage response, is delighted to announce the closure of the first tranche of its series A1 financing r...
Temedica GmbH Extends Series B with €25m to Total of €42m (2022-11-23)
> The Series B funding was extended by 25 million euros to reach a total of 42 million euros > The new funding enables a further expansion of the Temedica ecosystem, which provides holistic insights into the care realities and patient journeys of millions of pat...
Oxford Biomedica Appoints Frank Mathias as CEO (2022-11-22)
Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Company”), a leading gene and cell therapy group, today announces the appointment of Dr Frank Mathias as Chief Executive Officer (CEO) and Board Director, effective March 2023. Dr Mathias brings world-cl...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]